1 study found for:    18422971 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Trastuzumab in Combination With Capecitabine and Oxaliplatin(XELOX) in Patients With Advanced Gastric Cancer(AGC)
Conditions: Metastatic or Recurrent Gastric Adenocarcinoma;   Her-2 Positive Gastric Cancer
Intervention: Drug: Herceptin+XELOX

Indicates status has not been verified in more than two years